GPS Wealth Strategies Group’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$14.2K Sell
84
-18
-18% -$2.92K 0.01% 351
2025
Q3
$14.7K Sell
102
-22
-18% -$3K ﹤0.01% 990
2025
Q2
$15.7K Hold
124
﹤0.01% 913
2025
Q1
$15.9K Hold
124
﹤0.01% 886
2024
Q4
$16.4K Hold
124
﹤0.01% 843
2024
Q3
$18.1K Sell
124
-19
-13% -$2.75K ﹤0.01% 817
2024
Q2
$19.6K Sell
143
-28
-16% -$3.74K ﹤0.01% 766
2024
Q1
$23.5K Sell
171
-300
-64% -$41K ﹤0.01% 686
2023
Q4
$64K Sell
471
-35
-7% -$4.27K 0.01% 442
2023
Q3
$61.9K Buy
506
+40
+9% +$5.09K 0.01% 435
2023
Q2
$59.2K Sell
466
-25
-5% -$3.25K 0.01% 458
2023
Q1
$63.4K Buy
+491
New +$64.3K 0.01% 436
2022
Q4
Sell
-508
Closed -$59K 564
2022
Q3
$59K Hold
508
0.01% 401
2022
Q2
$60K Sell
508
-42
-8% -$4.99K 0.02% 410
2022
Q1
$72K Sell
550
-276
-33% -$36K 0.02% 363
2021
Q4
$126K Buy
826
+318
+63% +$49.2K 0.03% 262
2021
Q3
$82K Hold
508
0.02% 314
2021
Q2
$83K Sell
508
-55
-10% -$8.47K 0.02% 328
2021
Q1
$84K Buy
+563
New +$89.4K 0.02% 301

Other funds holding IBB

GPS Wealth Strategies Group's IBB Position: Q4 2025 in Review

GPS Wealth Strategies Group reduced its iShares Biotechnology ETF (IBB) stake by 18% in Q4 2025, selling an estimated $2.92K and leaving 84 shares worth $14.2K. The position accounts for 0.01% of the portfolio, ranked #351.

GPS Wealth Strategies Group first reported a position in IBB in Q1 2021 and has held it in 19 quarters since. The position peaked at $126K in Q4 2021. 958 funds tracked by Wall St. Rank hold IBB as of Q4 2025.

  • GPS Wealth Strategies Group held 84 shares of iShares Biotechnology ETF worth $14.2K as of Q4 2025.
  • GPS Wealth Strategies Group sold 18 iShares Biotechnology ETF shares in Q4 2025, an estimated $2.92K.
  • iShares Biotechnology ETF made up 0.01% of GPS Wealth Strategies Group's portfolio in Q4 2025, its #351 holding.
  • GPS Wealth Strategies Group first reported a position in iShares Biotechnology ETF in Q1 2021 and has held it in 19 quarters since.
  • GPS Wealth Strategies Group's iShares Biotechnology ETF position peaked at $126K in Q4 2021.
  • 958 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.